By Marc Levy

Children who lived closer to natural gas wells in heavily drilled western Pennsylvania were more likely to develop a relatively rare form of cancer, and nearby residents of all ages had an increased chance of severe asthma reactions, researchers said in reports released Tuesday evening.

The taxpayer-funded research by the University of Pittsburgh adds to a body of evidence suggesting links between the gas industry and certain health problems.

In the reports, the researchers found what they called significant associations between gas industry activity and two ailments: asthma, and lymphoma in children, who are relatively rarely diagnosed with this type of cancer.

The researchers were unable to say whether the drilling caused the health problems, because the studies weren’t designed to do that. Instead, the researchers combed health records to try to determine possible associations based on how close people lived to natural gas wells, while industry groups pointed to what they say are weaknesses of the studies’ assumptions and the limitations of its data.

The reports were released at the start of a Tuesday evening public meeting to discuss the findings, hosted by University of Pittsburgh School of Public Health and the state Department of Health, on the campus of state-owned Pennsylvania Western University.

At the meeting, community activists and distressed parents urged department officials and Pitt researchers to do more to protect public health as gas drilling continues to expand.

Raina Rippel, former director of the Southwest Pennsylvania Environmental Health Project, called the findings the “tip of the toxic iceberg and we are only just beginning to understand what is out there.”

There is, she warned, “a lot more cancer waiting in the wings.”

In the cancer study, researchers found that children who lived within 1 mile (1.6 kilometers) of a well had five to seven times the chance of developing lymphoma compared with children who lived 5 miles (8 kilometers) or farther from a well. That equates to 60 to 84 lymphoma cases per million children living near wells, versus 12 per million among kids living farther away.

For asthma, the researchers concluded that people with the breathing condition who lived near wells were more likely to have severe reactions while gas was being extracted compared with people who don’t live near wells. However, researchers said they found no consistent association for severe reactions during periods when crews were building, drilling and fracking the well.

The four-year, $2.5 million project is wrapping up after the state’s former governor, Democrat Tom Wolf, in 2019 agreed to commission it under pressure from the families of pediatric cancer patients who live amid the nation’s most prolific natural gas reservoir in western Pennsylvania.

An extremely rare form of bone cancer, Ewing sarcoma, had been diagnosed in dozens of children and young adults in a heavily drilled area outside Pittsburgh, and those families were instrumental in pushing Wolf to commission the study.

But the researchers said they found no association between gas drilling and childhood leukemia, brain and bone cancers.

Meanwhile, the researchers said their findings on preterm births and birth weights among families living closer to gas wells echoed the mixed conclusions in similar studies. There were hints that gas production might reduce birth weights by less than an ounce on average.

Edward Ketyer, a retired pediatrician who sat on an advisory board for the study, called the asthma findings a “bombshell.” He said he expected that the studies would be consistent with previous research showing the “closer you live to fracking activity, the increased risk you have of being sick with a variety of illnesses.”

“The biggest question is, why is anybody surprised about that?” said Ketyer, who is president of Physicians for Social Responsibility Pennsylvania.

A number of states have strengthened their laws around fracking and waste disposal over the past decade. However, researchers have repeatedly said that regulatory shortcomings leave an incomplete picture of the amount of toxic substances the industry emits into the air, injects into the ground or produces as waste.

The Pennsylvania-funded study comes on the heels of other studies that found higher rates of cancer, asthma, low birth weights and other afflictions among people who live near drilling fields around the country.

The gas industry has maintained that fracking is safe, and groups reviewing the studies said Tuesday that protecting public health is their highest priority.

The study’s findings are emerging under new Gov. Josh Shapiro, also a Democrat, who succeeded Wolf in January. His administration said Tuesday that it is working on various fronts to improve public health in response to the studies.

The advent of high-volume hydraulic fracturing combined with horizontal drilling miles deep in the ground over the past two decades transformed the United States into a worldwide oil and gas superpower.

But it also brought a torrent of complaints about water and air pollution, and diseases and ailments, as it encroached on exurbs and suburbs in states including Texas, Colorado and Pennsylvania.

Establishing the cause of health problems is challenging.

It can be difficult or impossible for researchers to determine exactly how much exposure people had to pollutants in air or water, and scientists often cannot rule out other contributing factors.

Because of that, environmental health researchers try to gather enough data to gauge risk and draw conclusions.

Share:
More In Science
FDA Authorizes Pfizer's Covid-19 Treatment Pill Marking Pandemic Milestone
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home. Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Markets Continue to Feel Omicron Pressures
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
An Omicron Christmas, Student Loans & Love, Hate, Ate
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer COVID Treatment Pill Gets FDA Authorization
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
Semiconductor Industry Warns Shortage Could Last Deep Into 2022
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Nomi Health Closes $110 Million to Further Scale Its Direct Healthcare Model Nationwide
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
Delta Airlines CEO Calls for Shortened Quarantine Times Amid Staffing Shortage
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
NASA to Launch The James Webb Space Telescope on Christmas Eve
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
The Importance of COVID-19 Tests in the Age of Omicron
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
Load More